Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Laffan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Medical Case Reports|November 25, 2021
Carboxymethylcellulose excipient allergy: a case reportKatherine Townsend, James Laffan, Grant Hayman
Clinical Medicine (London, England)|February 5, 2015
Lesson of the month 2: The limitations of steroid therapy in bradykinin-mediated angioedema attacksSharif Ismail, Leo Cheng, Sofia Grigoriadou, et al.
Clinical and Experimental Immunology|May 31, 2022
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UKAdrian M Shields, Ariharan Anantharachagan, Gururaj Arumugakani, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Medical Case Reports|November 25, 2021
Carboxymethylcellulose excipient allergy: a case reportKatherine Townsend, James Laffan, Grant Hayman
Clinical Medicine (London, England)|February 5, 2015
Lesson of the month 2: The limitations of steroid therapy in bradykinin-mediated angioedema attacksSharif Ismail, Leo Cheng, Sofia Grigoriadou, et al.
Clinical and Experimental Immunology|May 31, 2022
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UKAdrian M Shields, Ariharan Anantharachagan, Gururaj Arumugakani, et al.
Pageof 1